These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 15661826)

  • 1. The role of preimplantation genetic diagnosis in the management of severe rhesus alloimmunization: first unaffected pregnancy: case report.
    Seeho SK; Burton G; Leigh D; Marshall JT; Persson JW; Morris JM
    Hum Reprod; 2005 Mar; 20(3):697-701. PubMed ID: 15661826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A curious case of anti-D antibody titer.
    Hensley JG; Coughlin KP; Klein LL
    J Midwifery Womens Health; 2009; 54(6):497-502. PubMed ID: 19879523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RHD genotyping from maternal plasma: guidelines and technical challenges.
    Avent ND
    Methods Mol Biol; 2008; 444():185-201. PubMed ID: 18425481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RhD haemolytic disease of the fetus and the newborn.
    Urbaniak SJ; Greiss MA
    Blood Rev; 2000 Mar; 14(1):44-61. PubMed ID: 10805260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal anemia due to non-Rhesus-D red-cell alloimmunization.
    Moise KJ
    Semin Fetal Neonatal Med; 2008 Aug; 13(4):207-14. PubMed ID: 18396474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive prenatal diagnosis and determination of fetal Rh status.
    van der Schoot CE; Hahn S; Chitty LS
    Semin Fetal Neonatal Med; 2008 Apr; 13(2):63-8. PubMed ID: 18249590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal determination of fetal RhD type by DNA amplification.
    Bennett PR; Le Van Kim C; Colin Y; Warwick RM; Chérif-Zahar B; Fisk NM; Cartron JP
    N Engl J Med; 1993 Aug; 329(9):607-10. PubMed ID: 8341334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The importance of antenatal immunoprophylaxis for prevention of hemolytic disease of the fetus and newborn].
    Starcević M; Mataija M; Sović D; Dodig J; Matijević R; Kukuruzović M
    Acta Med Croatica; 2011 Mar; 65(1):49-54. PubMed ID: 21568074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An increased risk for non allo-immunization related intrauterine fetal death in RhD-negative patients.
    Ben-David G; Sheiner E; Levy A; Erez O; Mazor M
    J Matern Fetal Neonatal Med; 2008 Apr; 21(4):255-9. PubMed ID: 18330822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive prenatal diagnosis of fetal Rhesus D: ready for Prime(r) Time.
    Bianchi DW; Avent ND; Costa JM; van der Schoot CE
    Obstet Gynecol; 2005 Oct; 106(4):841-4. PubMed ID: 16199645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preimplantation genetic diagnosis: state of the art.
    Basille C; Frydman R; El Aly A; Hesters L; Fanchin R; Tachdjian G; Steffann J; LeLorc'h M; Achour-Frydman N
    Eur J Obstet Gynecol Reprod Biol; 2009 Jul; 145(1):9-13. PubMed ID: 19411132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of maternal plasma for prenatal RhD blood group genotyping.
    Finning K; Martin P; Daniels G
    Methods Mol Biol; 2009; 496():143-57. PubMed ID: 18839110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative.
    Chilcott J; Tappenden P; Lloyd Jones M; Wight J; Forman K; Wray J; Beverley C
    BJOG; 2004 Sep; 111(9):903-7. PubMed ID: 15327602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal CW alloimmunization.
    Bowman JM; Pollock J
    Vox Sang; 1993; 64(4):226-30. PubMed ID: 8517051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fetal and neonatal outcomes of Rhesus D antibody affected pregnancies in Northern Ireland.
    Craig S; Morris K; Tubman T; McClure B
    Ir Med J; 2000; 93(1):17-8. PubMed ID: 10740367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preimplantation genetic diagnosis of skin fragility-ectodermal dysplasia syndrome.
    Fassihi H; Grace J; Lashwood A; Whittock NV; Braude PR; Pickering SJ; McGrath JA
    Br J Dermatol; 2006 Mar; 154(3):546-50. PubMed ID: 16445790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
    Miquel E; Cavelier B; Bonneau JC; Rouger P
    Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rh (D) alloimmunization and pregnancy. Analysis of the causes after prophylaxis introduction].
    Furundarena JR; Ibisate A; Burguete Y; González de Langarica E; González N; Urquiza R; Mendizabal A; Hernando N; Pérez Clausell C
    Sangre (Barc); 1999 Dec; 44(6):429-33. PubMed ID: 10822755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood--a meta-analysis.
    Geifman-Holtzman O; Grotegut CA; Gaughan JP
    Am J Obstet Gynecol; 2006 Oct; 195(4):1163-73. PubMed ID: 17000250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal determination of fetal RhD (rhesus positive) type by an amplification of DNA.
    Kvasnicka J; Rypácková B; Calda P; Hájek Z
    Sb Lek; 1998; 99(1):13-20. PubMed ID: 9748794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.